Alvotech (ALVOW) Cash & Current Investments (2020 - 2025)
Alvotech (ALVOW) reported Cash & Current Investments of $172.4 million for Q4 2025, up 235.15% on a YoY basis from $51.4 million in Q4 2024, and up 335046.22% quarter-over-quarter from $51428.0 in Q3 2025.
Alvotech (ALVOW) Cash & Current Investments (2020 - 2025) Analysis & Trends
Alvotech has reported Cash & Current Investments for 6 years, with the latest figure at $172.4 million in Q4 2025.
- For the quarter ending Q4 2025, Cash & Current Investments rose 235.15% year-over-year to $172.4 million; the trailing twelve-month figure through Dec 2025 stood at $172.4 million (up 235.15% YoY), and the FY2025 full-year result was $172.4 million, up 235.15% from the prior year.
- Cash & Current Investments for Q4 2025 stood at $172.4 million, up from $51428.0 in the prior quarter.
- The five-year high for Cash & Current Investments was $172.4 million in Q4 2025, with the low at $51428.0 in Q3 2025.
- Historically, Cash & Current Investments has averaged $57.8 million across 5 years, with a median of $51.4 million in 2024.
- The largest YoY upside for Cash & Current Investments was 369.92% in 2025 against a maximum downside of 99.96% in 2025.
- Alvotech's Cash & Current Investments stood at $17.6 million in 2021, then soared by 278.37% to $66.4 million in 2022, then slumped by 83.2% to $11.2 million in 2023, then surged by 360.95% to $51.4 million in 2024, then soared by 235.15% to $172.4 million in 2025.
- The last three Cash & Current Investments figures came in at $172.4 million (Q4 2025), $51428.0 (Q3 2025), and $51.4 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 3.74 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | 1.94 Bn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 2.15 Bn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 77.77 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 1.32 Bn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | 428.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | 511.86 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 498.58 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 750.88 Mn |
| 10 | Alvotech | - | - | -22.39 Mn | 172.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 172.36 Mn |
| Sep 30, 2025 | 51,428.00 |
| Jun 30, 2025 | 51.43 Mn |
| Mar 31, 2025 | 51.43 Mn |
| Dec 31, 2024 | 51.43 Mn |
| Sep 30, 2024 | 118.27 Mn |
| Jun 30, 2024 | 10.94 Mn |
| Mar 31, 2024 | 64.81 Mn |
| Dec 31, 2023 | 11.16 Mn |
| Jun 30, 2023 | 60.47 Mn |
| Mar 31, 2023 | 115.84 Mn |
| Dec 31, 2022 | 66.43 Mn |
| Jun 30, 2022 | 17.56 Mn |
| Dec 31, 2021 | 17.56 Mn |
| Dec 31, 2020 | 31.69 Mn |